Analytical Development Co-Op

Company Summary:

FL87, Inc. is a privately held, early-stage biotechnology company developing a novel approach to gene therapy that can address currently untreatable diseases.

FL87 was founded by Flagship Pioneering, an innovation enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Syros Pharmaceuticals (SYRS), Seres Therapeutics (NASDAQ:MCRB), Generate Biomedicines, Tessera Tx, Evelo Biosciences (EVLO), and Indigo Agriculture.

Position Summary:

We are searching for an experienced and enthusiastic Co-Op, Analytical Development to support the development of novel methods to manufacturing and characterization of novel nucleic acid therapeutics. We are looking for an individual who enjoys hands-on laboratory benchwork and brings scientific rigor and intellectual curiosity to their role. This individual will have the opportunity to work in a dynamic and fast-paced entrepreneurial environment as part of a highly collaborative and rapidly growing team.

Key Responsibilities:

Work with the team to drive advancement of platform development developing methods for scalable, rigorous, and cost-effective manufacturing and quality control. Step into benchwork to execute platform goals with tenacity, agility, and timeliness.  

• The successful candidate will work as part of the team responsible for the development, characterization, and production of nucleic acid therapeutics
• Synthesize, purify, and characterize routine nucleic acid products for preclinical studies
• Help establish and optimize nucleic acid manufacturing scale-up capability
• Help develop scalable strategies for upstream and downstream nucleic acid production
• Carry out process development studies using the design-of-experiments approach
• Develop and execute analytical assays for the characterization and release of nucleic acid cargo
• Analyze, summarize, and present experimental results to team members and management
• Explore new technologies and methods to optimize current processes in fast-paced research environment
• Maintain up-to-date records and communicate results to team members in written technical reports and oral presentations
• Participate in experimental design and troubleshooting efforts
• Interpret, summarize experimental data and maintain excellent laboratory notebooks

Qualifications:

• Current student enrolled in a Bachelors or Master’s program in Chemical Engineering, Biochemical Engineering, Bioengineering, Biomolecular Engineering, Chemistry, Biochemistry, Biomedical Engineering, Biophysics, Biostatistics, Biotechnology, Mathematics, Molecular Biology, Pharmaceutical Science, Statistics, or a related field
• Strong fundamental scientific and engineering skills for the evaluation of experimental data
• Laboratory skills applicable to bioprocess development and analytical methods
• GPA of 3.5 on a 4 scale or equivalent

• Attention to detail, ability to multi-task, and trouble-shoot
• Strong written and verbal communication skills
• Excellent record keeping and data management skills
• The ideal candidate is adaptable, enthusiastic about new challenges, has an innate curiosity, and a passion for learning
• Experience working in fast-paced startup environments
• Excellent organization skills, approaching tasks with efficiency
• Ability to analyze, summarize, and communicate scientific data
• Ability to work independently while effectively interacting and collaborating in a team environment

More About Flagship Pioneering

We are creative optimists and we would love for you to consider joining our team!  See all our open opportunities across Flagship Pioneering’s Ecosystem!

Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including:  Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO),  Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS).

We believe pioneering is best done by teams, and that it is a process that can be taught, learned, and replicated.  Learn more about our Company Creation Model.

Can Breakthrough Innovations Be Made Systematically? A Conversation With Noubar Afeyan, Flagship Pioneering’s CEO.

Flagship Pioneering and our ecosystem companies are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.

 

The salary range for this role is $20 - $40. Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. FL87 currently offers healthcare coverage, annual incentive program, retirement benefits and a broad range of other benefits. Compensation and benefits information is based on FL87’s good faith estimate as of the date of publication and may be modified in the future.